The latest closing stock price for Travere Therapeutics as of April 17, 2025 is 14.92.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2003 would have $-974 today, roughly -1 times their original investment - a -15.36% compound annual growth rate over 22 years.
The all-time high Travere Therapeutics stock closing price was 675.00 on August 20, 2003.
The Travere Therapeutics 52-week high stock price is 25.29, which is 69.5% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 65.7% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 14.22.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2003 would have $-974 today, roughly -1 times their original investment - a -15.36% compound annual growth rate over 22 years.
The all-time high Travere Therapeutics stock closing price was 675.00 on August 20, 2003.
The Travere Therapeutics 52-week high stock price is 25.29, which is 69.5% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 65.7% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 14.22.